NRX Pharmaceuticals (NRXP) Earnings Date & Reports

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRXP is expected to report earnings to fall 74.25% to -11 cents per share on November 16

NRX Pharmaceuticals NRXP Stock Earnings Reports

Q3'26

Est.

$-0.11

Q2'26

Missed

by $0.33

Q4'25

Beat

by $0.53

Q3'25

Beat

by $0.25

Q2'25

Missed

by $0.45

The last earnings report on August 17 showed earnings per share of -43 cents, missing the estimate of -11 cents. With 488.20K shares outstanding, the current market capitalization sits at 144.39M.

View a ticker or compare two or three

NRXP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days